Page 173 - CW E-Magazine (31-10-2023)

Special Report

Sustainability efforts in the Indian pharmaceutical

companies

ustainability has gained signifi - DR. AJIT JOSHI
cant traction across many indus- Email: drjoshi9@gmail.com
Stry sectors worldwide in the past
several years. Almost every company Sustainability covers a wide range
in the world is making efforts to make of actions with respect to operations of
their operations sustainable so as to an organization or company – starting
reduce their negative impact on nature. nomic resources along with the natural from simple conservation to modifying
resources. It is not only environmental chemical reactions used.
In short, sustainability may be de- conservation, but also embeds social
fi ned as the capacity to maintain or equity and economic development. Indian pharmaceutical companies
support the availability of desirable Sustainability is considered a part of have been taking efforts to implement
natural materials continuously over a intergenerational ethics and ensures long sustainability measures at various
long period of time. It means meeting term viability of a community. In busi- levels in their operations. This article
the needs of our generation without ness and policy contexts, sustainability reviews these efforts by selected pharma-
compromising the ability of future gene- seeks to prevent depletion of natural or ceutical companies in India.
rations to meet their own needs. Sus- physical resources, so that they will re-
tainability also covers social and eco- main available for the long term. Indian pharmaceutical industry
Table 1: Top 20 Indian pharmaceutical companies by sales in 2022-23 The Indian pharmaceutical industry
[Rs. Crore] supplies a wide range of pharmaceuti-
cals – APIs as well as formulations –
Rank Company Sales across the world. It is the world’s third
1 Sun Pharmaceutical Industries 43,279 largest by volume and 13th largest by
2 Divi’s Laboratories 24,617 value globally. The major segments of
the domestic pharmaceutical industry
3 Dr. Reddy’s Laboratories 24,588 include generic drugs, over-the-counter
4 Cipla 22,473 (OTC) medicines, bulk drugs, vaccines,
5 Emcure Pharmaceuticals 18,987 biosimilars and biologics, and contract
6 Biocon 17,631 research and manufacturing (CRAM)
services. Pharmaceutical companies
7 Torrent Pharmaceuticals 16,878 in India are the largest providers of
8 Lupin 16,249 generic medicines by volume, with a 20%
9 Zydus Lifesciences 15,683 share of the global market. Medicines
and other pharmaceutical products are
10 Aurobindo Pharma 15,168 exported to over 200 countries from
11 Intas Pharmaceuticals 14,657 India. Skilled workforce, cost competi-
12 Glenmark Pharma 14,146 tiveness, strong R&D capabilities, as
13 Mankind Pharma 13,634 well as positive government support
are important strengths of the Indian
14 Abbott India 13,123 pharmaceutical industry. The Indian
15 Alkem Laboratories 12,612 pharmaceutical industry is a key sector
16 Alembic Pharmaceuticals 12,101 of the Indian economy and plays a vital
role in providing affordable healthcare
17 Piramal Enterprises 11,590 to people around the world.
18 Laurus Labs 11,079
The National Stock Exchange
19 Pfi zer India 10,568 (NSE) has a separate stock index for
20 GlaxoSmithKline Pharmaceuticals 10,057 listed Indian pharmaceutical companies

Chemical Weekly October 31, 2023 173

Contents Index to Advertisers Index to Products Advertised